Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for reducing bleeding during brain tumor surgery
IRCT20250521065834N1Phase 4Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of tranexamic acid in brain neoplasm (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Amount of bleeding and Amount of packed cell transfused. Started May 2025; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on IRCT20250521065834N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250521065834N1.